[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2036186T3 - 3-amino-dihidropiridinas, un procedimiento para su obtencion y su empleo en medicamentos. - Google Patents

3-amino-dihidropiridinas, un procedimiento para su obtencion y su empleo en medicamentos.

Info

Publication number
ES2036186T3
ES2036186T3 ES198787106013T ES87106013T ES2036186T3 ES 2036186 T3 ES2036186 T3 ES 2036186T3 ES 198787106013 T ES198787106013 T ES 198787106013T ES 87106013 T ES87106013 T ES 87106013T ES 2036186 T3 ES2036186 T3 ES 2036186T3
Authority
ES
Spain
Prior art keywords
medicines
procedure
dihidropiridinas
amino
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787106013T
Other languages
English (en)
Inventor
Jurgen D.I. Stoltefuss
Fred Robert Dr. Heiker
Martin Dr. Bechem
Rainer Prof. Dr. Gross
Michael Dr. Kayser
Matthias Dr. Schramm
Gunter Dr. Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2036186T3 publication Critical patent/ES2036186T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A DIHIDROPIRIDINAS DE LA FORMULA GENERAL (I) CON LAS DEFINICIONES DE LOS SUSTITUYENTES QUE SE INDICAN EN LA DESCRIPCION, UN PROCEDIMIENTO PARA SU PREPARACION Y SU EMPLEO EN MEDICAMENTOS, ESPECIALMENTE EN MEDICAMENTOS QUE INFLUYEN SOBRE LA CIRCULACION.
ES198787106013T 1986-05-07 1987-04-24 3-amino-dihidropiridinas, un procedimiento para su obtencion y su empleo en medicamentos. Expired - Lifetime ES2036186T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863615404 DE3615404A1 (de) 1986-05-07 1986-05-07 Salze von 3-amino-dihydropyridinen, ein verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
ES2036186T3 true ES2036186T3 (es) 1993-05-16

Family

ID=6300317

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787106013T Expired - Lifetime ES2036186T3 (es) 1986-05-07 1987-04-24 3-amino-dihidropiridinas, un procedimiento para su obtencion y su empleo en medicamentos.

Country Status (14)

Country Link
US (1) US4772611A (es)
EP (1) EP0244713B1 (es)
JP (1) JP2528465B2 (es)
KR (1) KR870011092A (es)
AT (1) ATE55599T1 (es)
CA (1) CA1283106C (es)
DE (2) DE3615404A1 (es)
DK (1) DK231787A (es)
ES (1) ES2036186T3 (es)
FI (1) FI871984A (es)
GR (1) GR3000725T3 (es)
HU (1) HU198182B (es)
IL (1) IL82419A (es)
ZA (1) ZA873224B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2594167B2 (ja) * 1990-05-21 1997-03-26 明治製菓株式会社 新規抗生物質ｓｆ２６９８物質およびその製造法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5720952B2 (es) * 1974-04-10 1982-05-04
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines

Also Published As

Publication number Publication date
DE3615404A1 (de) 1987-11-12
EP0244713B1 (de) 1990-08-16
EP0244713A3 (en) 1988-09-07
FI871984A0 (fi) 1987-05-05
JP2528465B2 (ja) 1996-08-28
IL82419A (en) 1991-06-10
HUT44502A (en) 1988-03-28
HU198182B (en) 1989-08-28
GR3000725T3 (en) 1991-10-10
IL82419A0 (en) 1987-11-30
DE3764302D1 (de) 1990-09-20
DK231787A (da) 1987-11-08
CA1283106C (en) 1991-04-16
DK231787D0 (da) 1987-05-06
EP0244713A2 (de) 1987-11-11
ZA873224B (en) 1987-10-28
JPS62263154A (ja) 1987-11-16
FI871984A (fi) 1987-11-08
ATE55599T1 (de) 1990-09-15
US4772611A (en) 1988-09-20
KR870011092A (ko) 1987-12-19

Similar Documents

Publication Publication Date Title
ES2037013T3 (es) Procedimiento para preparar tieno-1,4-diazepinas.
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2058070T3 (es) Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.
MX9203226A (es) Derivados de fenetanolamina y composicion farmaceutica que los contiene.
MX9202639A (es) Nuevos derivados del acido 2,4,6-triyodo-isoftalico y composiciones de contraste que los contienen.
ES2060611T3 (es) Fotoiniciadores correactivos.
MX9203380A (es) Derivados de carbazolil-(4)-oxi-propanolamina y composiciones farmaceuticas que los contienen.
MX9203040A (es) Derivados de quinona y composicion farmaceutica que los contiene.
MX9524A (es) Derivados de catecol y procedimiento para su preparacion y composiciones que los contienen.
ES2042737T3 (es) Un procedimiento para la preparacion de un glucosido de antraciclina.
MX9203126A (es) Derivados de sulfonilurea y composiciones farmaceuticas que los contienen.
AR220307A1 (es) Compuestos de condensacion de glicidol sobre las diglicolamidas de cadena grasa,procedimiento para prepararlos y las composiciones cosmeticas que las contienen
IT1146175B (it) Procedimento per la preparazione di derivati di resorcinolo
SE8401537D0 (sv) Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande ibuprofen och sett att anvenda dessa
ES2054650T3 (es) Fenilacetonitrilos basicamente substituidos, su obtencion y medicamentos que los contienen.
ES2018667B3 (es) Derivados del acido 4-qionolon-3-carboxilico, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
AR241022A2 (es) "fosfatidos de eteres de glicerina y procedimiento para su preparacion"
IT7921922A0 (it) Procedimento per la determinazione dell'attivita' della colinesterasi e derivati della colina che vengono impiegati nel procedimento.
AR226809A1 (es) Fenil-bencimidazolil-furanos,procedimiento para su obtencion y composiciones que los contienen
MX6424A (es) Derivados de tripeptidos, procedimientos para la preparacion de derivados de tripeptidos y composiciones que los contienen.
ES2100263T3 (es) Nuevas isohirudinas sinteticas con estabilidad mejorada.
ES2036186T3 (es) 3-amino-dihidropiridinas, un procedimiento para su obtencion y su empleo en medicamentos.
ES2021634B3 (es) Procedimiento para la eliminacion del eter de dimetilo en cloruro de metilo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 244713

Country of ref document: ES